Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

UNITEDHEALTH GROUP (UNH)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 04/20 10:00:44 pm
235.06 USD   -0.30%
04:53aCEO PAY WATCH : Stephen Hemsley, UnitedHealth Group executive chairm..
AQ
04/20UNITEDHEALTH : Getting government help
AQ
04/18UNITEDHEALTH : Outlook Improves -- WSJ
DJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

UnitedHealth Earnings Slip, But Revenue Climbs

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/17/2013 | 03:08pm CEST

--Earnings down slightly on fewer excess reserves

--EPS still tops Street, but not by wide margins as in recent quarters

--Company cites good full-year cost trend for commercial business

(Updates throughout with details on results, analyst comment.)

 
   By Jon Kamp 
 

UnitedHealth Group Inc.'s (>> UnitedHealth Group Inc.) fourth-quarter earnings slipped slightly as the health insurer benefited less from excess reserves set aside to cover member costs. Revenue, though, surged on growing membership, and the company saw improved profits in its big health-services business.

The Minnetonka, Minn., company squeaked in ahead of Wall Street's per-share earnings expectations for the quarter, although not by the same margin as in recent quarters. Shares slipped 1.2% to $53 in premarket trading Thursday.

Analysts still said it was a good quarter for the industry bellwether, the largest managed-care company by revenue and typically the first to report quarterly results.

The "results look quite solid even though lacking the upside of prior [UnitedHealth] quarters" last year, Goldman Sachs analyst Matthew Borsch said.

UnitedHealth--which has taken a cautious view of potential pressure points this year, such as the still-weak economy--backed the 2013 financial guidance it issued in late November.

The company also noted a potentially good development regarding medical costs for its big commercial health-insurance business: Full-year costs trend rose less than expected.

Still, UnitedHealth's consolidated medical-care ratio, which reflects the portion of insurance premiums used for patient care, increased to 80.5% in the fourth quarter from 79.7% a year earlier. The increase reflects the smaller level of excess reserves. When patients rack up fewer bills than expected, the extra money set aide to cover costs benefits earnings.

UnitedHealth reported a profit of $1.24 billion, or $1.20 a share, compared with $1.26 billion, or $1.17 a share, a year earlier. The company had fewer shares outstanding in the recent quarter.

Revenue jumped 11% to $28.77 billion. Analysts polled by Thomson Reuters had forecast earnings of $1.19 a share on revenue of $28.24 billion.

Revenue got a boost from UnitedHealth's recent purchase of a majority stake in Brazilian insurer and hospital operator Amil Participacoes S/A (AMPIY, AMIL3.BR). UnitedHealth owns 65% of Amil and expects to buy an additional 25% in the first half of this year. The total deal is valued at about $4.3 billion in cash.

UnitedHealth's insurance business saw its revenue increase 11% to $26.9 billion in the recent quarter.

Revenue from Optum, the company's information- and technology-based health-services business, declined 1.3% to $7.5 billion, but the operating margin there rose to 6.1% from 3.7% a year earlier. UnitedHealth cited growth in higher margin products and efficiency improvements.

The company ended the year with 40.9 million medical members, including members added through the Amil deal, up 18% from a year earlier.

--Melodie Warner contributed to this article.

Write to Jon Kamp at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : UnitedHealth Group Inc.
Stocks mentioned in the article
ChangeLast1st jan.
AMIL PARTICIPACOES SA 1.07% 32.2 End-of-day quote.0.00%
GOLDMAN SACHS GROUP -0.87% 251.96 Delayed Quote.-0.23%
UNITEDHEALTH GROUP -0.30% 235.06 Delayed Quote.6.94%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on UNITEDHEALTH GROUP
04:53aCEO PAY WATCH : Stephen Hemsley, UnitedHealth Group executive chairman
AQ
04/20UNITEDHEALTH : Getting government help
AQ
04/20UNITEDHEALTH : National Business Group on Health Honors Atrium Healths Levine Ca..
AQ
04/19UNITEDHEALTH : Patent Issued for Intelligent Presence Server Systems and Methods..
AQ
04/18UNITEDHEALTH : Outlook Improves -- WSJ
DJ
04/17UnitedHealth and Alphabet climb; Tesla and Comerica skid
AQ
04/17UNITEDHEALTH : hikes outlook after quarterly profit easily beats estimates
AQ
04/17UNITEDHEALTH : Increases Guidance for Year -- Update
DJ
04/17UNITEDHEALTH GROUP INCORPORATED (NYS : UNH) Files An 8-K Results of Operations a..
AQ
04/17MARKETS RIGHT NOW : Stocks close higher, extending gains
AQ
More news
News from SeekingAlpha
04/19DIVIDEND CHALLENGERS (AND NEAR-CHALL : 53 Increases By June 30 
04/18CLOSED-END FUND THQ : Large-Cap Healthcare Stocks At An 8% Yield 
04/18WALL STREET BREAKFAST : Tesla Doubles Down On Model 3 
04/17UnitedHealth Group's (UNH) CEO Andrew Hayek on Q1 2018 Results - Earnings Cal.. 
04/17UnitedHealth Q1 revenues up 13%; non-GAAP EPS up 28%; updates 2018 guidance 
Financials ($)
Sales 2018 225 B
EBIT 2018 17 391 M
Net income 2018 11 768 M
Debt 2018 15 231 M
Yield 2018 1,22%
P/E ratio 2018 19,88
P/E ratio 2019 17,39
EV / Sales 2018 1,08x
EV / Sales 2019 0,98x
Capitalization 227 B
Chart UNITEDHEALTH GROUP
Duration : Period :
UnitedHealth Group Technical Analysis Chart | UNH | US91324P1021 | 4-Traders
Technical analysis trends UNITEDHEALTH GROUP
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 277 $
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
David Scott Wichmann President, Chief Executive Officer & Director
Stephen J. Hemsley Executive Chairman
John Franklin Rex Chief Financial Officer
Richard J. Migliori Chief Medical Officer & EVP-Medical Affairs
Richard T. Burke Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
UNITEDHEALTH GROUP6.94%227 459
AETNA-1.92%57 877
ANTHEM INC0.47%57 840
CIGNA-15.44%41 269
HUMANA18.92%40 496
CENTENE CORPORATION9.66%19 362